BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Concerns with Merck & Co., Inc. (JOBS) Cholesterol Study

  July 10, 2009

   · 

  1 min read
• Business

  InNexus Inc. and Genhelix to Combine Antibody Development and Manufacturing Resources

  July 10, 2009

   · 

  1 min read
• Drug Development

  Uni-Bio to Begin Phase III Trial of Diabetes Drug

  July 10, 2009

   · 

  1 min read
• BioMidwest

  First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery, Inc. Devices

  July 10, 2009

   · 

  4 min read
• Deals

  Vertex Pharmaceuticals Incorporated to Sell Rights to Hepatitis C Drug Payments

  July 10, 2009

   · 

  3 min read
• Pharm Country

  Watson Pharmaceuticals, Inc. Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)

  July 10, 2009

   · 

  3 min read
• Business

  Dr. Richard Rosenbloom Resumes Services To The Quigley Corporation’s Pharma Subsidiary

  July 10, 2009

   · 

  2 min read
• Business

  Watson Pharmaceuticals, Inc. to Host Second Quarter 2009 Earnings Conference Call and Webcast

  July 10, 2009

   · 

  1 min read
• Drug Development

  EpiCept Corporation Initiates Post-Approval Clinical Study with Ceplene(R)

  July 10, 2009

   · 

  1 min read
• Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting

  July 10, 2009

   · 

  4 min read